BiotechTube
Home/Sensorion/Nawal Ouzren
NO

Nawal Ouzren

Chief Executive Officer

Sensorion

Therapeutic Areas

OtologyHearing LossInner Ear Disorders

Sensorion Pipeline

DrugIndicationPhase
OTOF-GT (SENS-501)Otoferlin Deficiency (Auditory Neuropathy)Phase 1/2
GJB2-GTEarly Presbycusis linked to GJB2Preclinical
SENS-401Hearing Preservation after Cochlear ImplantationPhase 2

Leadership Team at Sensorion

KL
Karine Lignel
Chief Financial Officer
DG
Dr. Géraldine Honnet
Chief Medical Officer
DB
Dr. Bénédicte Lignel-Jouenne
Head of Corporate Strategy
View full Sensorion profile